Tumor suppressor p53 regulates intestinal type 2 immunity
Open Access
- 7 June 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Abstract
The role of p53 in tumor suppression has been extensively studied and well-established. However, the role of p53 in parasitic infections and the intestinal type 2 immunity is unclear. Here, we report that p53 is crucial for intestinal type 2 immunity in response to the infection of parasites, such asTritrichomonas murisandNippostrongylus brasiliensis. Mechanistically, p53 plays a critical role in the activation of the tuft cell-IL-25-type 2 innate lymphoid cell circuit, partly via transcriptional regulation of Lrmp in tuft cells. Lrmp modulates Ca2+influx and IL-25 release, which are critical triggers of type 2 innate lymphoid cell response. Our results thus reveal a previously unrecognized function of p53 in regulating intestinal type 2 immunity to protect against parasitic infections, highlighting the role of p53 as a guardian of immune integrity.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R01CA227912, 1R01CA214746, 1R01CA160558, 1R01CA203965)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of War (W81XWH-18-10238)
This publication has 55 references indexed in Scilit:
- LIF is essential for ISC function and protects against radiation-induced gastrointestinal syndromeCell Death & Disease, 2020
- A single-cell survey of the small intestinal epitheliumNature, 2017
- Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathwayCell Death & Disease, 2016
- Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasitesNature, 2016
- IL-25-responsive, lineage-negative KLRG1hi cells are multipotential ‘inflammatory’ type 2 innate lymphoid cellsNature Immunology, 2014
- Mutant p53 in Cancer: New Functions and Therapeutic OpportunitiesCancer Cell, 2014
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- Dual Role of p53 in Innate Antiviral ImmunityViruses, 2010
- Lrmp/Jaw1 is Expressed in Sweet, Bitter, and Umami Receptor-Expressing CellsChemical Senses, 2010
- p53 regulates maternal reproduction through LIFNature, 2007